AUG 10, 2018 06:00 AM PDT

Cancer Cell 'Drones' Battle Immune System

Worldwide 8.8 million people die of cancer, that is almost 1 in 6 of all global deaths, and is the second leading cause of death globally. The most common cancers among men are lung, prostate, colorectal, stomach and liver while breast, colorectal, lung, cervix, and stomach cancer are most common among women. In all types of cancer, the body’s cells divide without stopping and spread to surrounding tissues. It can start almost anywhere in the human body and breaks up the orderly process of cell division and cell death. Cells become abnormal, old, and survive despite having damage, with new cells forming even if they are not needed. As cancerous cells continue to divide, they crowd out healthy cells and form growths called tumors, making it hard for the body to function correctly.  

Credit: The labs of Wei Guo, PhD, and Xiaowei Xu, MD, PhD, University of Pennsylvania.

Cancer cells suppress the immune system to allow tumors and cancerous cells to thrive and spread unchecked in the body. One of the most significant innovations in cancer therapy is checkpoint inhibitor drugs. These drugs block attempts by a cancer cell to suppress the immune system; a primary target is a T cell surface protein known as PD-1. Previous studies have found the PD-L1 protein on tumor cells interacts with the T cell counterpart PD-1 and turns off the T cell anti-cancer response. A recent study, published in Nature, shows that cancer cells combat the immune system by releasing the biological version of drones carrying PD-L1 to assist in the fight.

The researchers from the University of Pennsylvania showed small vesicles, known as exosomes, circulate the blood armed with PD-L1 proteins that cause T cells to tire before they even reach the tumor to do battle. This discovery of PD-L1 on exosomes provides a new outlook on the immune checkpoint mechanism and offers novel insight into tumor immune evasion. While the study focused on metastatic melanoma, they did find PD-L1-carrying exosomes secreted by breast and lung cancer cells as well. Dr. Wei Guo, one of the collaborators on the work, said: "We propose a model in which these exosomes act like drones to fight against T cells in circulation, even before the T cells get near to the tumor."

These findings may allow for a less invasive measure of monitoring cancer/T cell battle through blood tests versus invasive biopsies of tumors. Measuring levels of PD-L1 before treatment may allow for prediction of tumor burden in a patient and utilize the information to predict treatment outcome. After initial treatment, researchers can use a blood test for PD-L1 levels to monitor how well drugs are keeping cancer cells in check. Much like we measure sugar levels in diabetes patients, it is possible that PD-L1 monitoring, along with other biomarkers on the circulating exosomes, could be utilized as a way to keep tabs on treatments and patient response in a similar manner. These findings are another step toward precision and personalized medicine in cancer treatment.

To learn more about cancer cells, how they spread, and treatment options watch the video below!

American Cancer Society, National Cancer Institute 

 

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
AUG 27, 2018
Cell & Molecular Biology
AUG 27, 2018
Stopping Cell Suicide
Chronic inflammation has been linked to many diseases and can trigger cell death....
SEP 03, 2018
Immunology
SEP 03, 2018
Insulin Boosts the Immune System
Insulin boosts T cells to better fight infection and bolster the immune response....
SEP 07, 2018
Health & Medicine
SEP 07, 2018
What's Behind the Massive Measles Outbreak in Europe?
Measles is a disease that many believe was eradicated years ago. That's true, to a point, but like a bad penny, it's back. In the United States, th...
OCT 31, 2018
Immunology
OCT 31, 2018
Masking the Pathogen
Researchers at Penn State have revealed bacterial pathogens capable of creating components used for DNA replication without the use of metal ions allowing them to evade the immune system...
NOV 12, 2018
Health & Medicine
NOV 12, 2018
Researchers find that obesity has a paradoxical effect on Cancer
Cancer therapy works differently in different people. Understanding what effects the individual body's response to treatment will be crucial for the development...
NOV 30, 2018
Microbiology
NOV 30, 2018
C-Section Deliveries Disrupt the Transmission of Microbes From Mom to Baby
From our earliest days, bacteria exert a powerful influence on many aspects of our health....
Loading Comments...